CMS Targets Protected Classes in Expanded Part D Demo

As one of its last actions under the Trump administration, CMS said it would give plan sponsors participating in its Medicare Part D Payment Modernization model more flexibility to slim down their formularies, even for protected classes of drugs. The changes to the model — which were included in the demo’s 2022 request for applications issued Jan. 19 — will also eliminate downside financial risk for plan sponsors, although that risk would return in 2023.

It’s unclear what effect these changes would have, since there’s currently been very low uptake of this voluntary model from the CMS Center for Medicare & Medicaid Innovation, with only two plans participating nationwide.

© 2023 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

bills-and-pills
January 26

Medicare Enrollees May Still Face Affordability Issues After Part D Benefit Redesign

READ MORE
pills-in-hand
January 26

ICER Report Aims to Nudge Payers Toward Fairer Drug Coverage Policies

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
January 26

News Briefs: Lilly Alzheimer’s Drug Fails to Win Accelerated Approval

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today